Concepedia

Yanfeng Wang

YW

195

Publications

12.8K

Citations

50

H-Index

1996

Active since

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Central South University

University of Pennsylvania

Novartis (United States)

Yanfeng Wang is an author at Zhongnan Hospital of Wuhan University specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

1996–2024

195

Publications

195

Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

Jeffrey D. Rothstein, Margaret Dykes‐Hoberg, Carlos A. Pardo et al. · Neuron · 1996 · 2.5K citations · Full text

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

Richard M. Stone, Daniel J. DeAngelo, Virginia M. Klimek et al. · Blood · 2004 · 659 citations · Full text

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Richard A. Larson, Brian Druker, François Guilhot et al. · Blood · 2008 · 631 citations · Full text

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn et al. · Clinical Cancer Research · 2006 · 426 citations

Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

George D. Demetri, Yanfeng Wang, Elisabeth Wehrle et al. · Journal of Clinical Oncology · 2009 · 396 citations · Full text

, , +16

Rows per page

1–5 of 195